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OBJECTIVE: Postal surveys only investigate HRQOL in
those who return questionnaires and also complete
enough information for analysis. Calculation of a single
index of HRQoL (EQ-5D index) is impossible where
data are missing. This study investigates completion of
EQ-5D and the factors associated with non-completion.
METHOD: A postal questionnaire was sent to 10,471
adults registered to two general practices in Manchester.
Non-responders received reminders after four and eight
weeks. Demographic information for non-responders was
obtained from general practitioner records. Indicators of
social deprivation were obtained from the Regional Health
Authority. EQ-5D rates 5 HRQOL domains on three lev-
els with overall health state marked on a visual analogue
scale (VAS) between 0 (worst) and 100 (best).
RESULTS: In total, 6838 (65.3%) questionnaires were
returned; 5954 (56.9%) were complete. The self-care do-
main was missed most often (5.6% of responders) fol-
lowed by anxiety/depression (4.4%), usual-activities (4.3%),
pain/discomfort (4.1%), and mobility (3.9%). There was
a significant difference in proportions between self-care
and anxiety/depression (4.4% vs 5.6%, difference 
0.121, 95% CI of difference 0.195 to 0.0481). Four
hundred thirty one people missed the VAS. Women were
more likely to miss domain questions (10.2% vs 7.7%,
chi2 12.67, p  .001) as were older respondents (mean
age 47.6 vs 57.7 t 12.16, p  .001). Missing data were
less common in those with further education or a degree
(10.3% vs 5.5% and 5.3% respectively, chi2 46.4, p 
0.001). Social deprivation was more common in those
who missed a question but this was not statistically sig-
nificant.
CONCLUSION: Low levels of non-completion were
found, although respondents were significantly less will-
ing to answer about self-care than about other domains,
possibly not wishing to appear dependent on others. The
importance of analyzing the degree of non-completion of
a questionnaire and possible associated factors should be
noted. Future work is needed to investigate HRQoL in
those who do not respond to or complete questionnaires.
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Anemia at diagnosis (baseline) is a potential adverse
prognostic factor for no response to chemotherapy in ad-
dition to the standard risk factors.
OBJECTIVE: The purpose of this study was to identify
factors associated with baseline anemia and to determine
risk factors associated with no response to CHOP che-
motherapy in IGNHL patients.
METHODS: A historical case series sample of 591 pa-
tients diagnosed between 1993 and 1999, and treated in
12 practice sites with CHOP chemotherapy was used.
Baseline anemia was defined as a hemoglobin (Hb) value
12 g/dl at baseline. Multiple logistic regression was
used to determine factors associated with baseline anemia
and model its relationship with response [no response
(NR) versus partial response (PR) and complete response
(CR)].
RESULTS: Anemia was present in 193/546 (35.3%) pa-
tients. Baseline Hb values were not available for 45 pa-
tients. Multiple logistic regression showed that baseline
anemia was significantly associated with elevated LDH
(OR; 95%CI) (OR  2.74; 1.66–4.50), presence of B
symptoms (OR  2.16; 1.22–3.83), stage III-IV (OR 
1.81: 1.10–2.93), male gender (0.42: 0.25–0.69), and
large cell diffuse (OR  2.05; 1.19–3.54) or immuno-
blast (3.99; 1.78–9.02) histologic types. No significant
interactions existed between any of the variables included
in this model. Multiple logistic regression (predicting NR
versus CR/PR) showed that the presence of baseline anemia
(OR  2.29; 1.10–4.74) controlling for elevated LDH,
advanced Stage III-IV, and age greater than or equal to
60, was a significant risk factor for NR to CHOP chemo-
therapy.
CONCLUSION: The results support previous findings of
the high prevalence of, and risk factors associated with,
baseline anemia prior to CHOP chemotherapy. Baseline
anemia was a significant risk factor for NR to CHOP
chemotherapy, even after controlling for age, stage, and
LDH. We conclude that additional studies with a com-
prehensive set of known risk factors validating this rela-
tionship between baseline anemia and response to CHOP
chemotherapy are warranted.
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OBJECTIVE: Breast cancer is one of the major causes of
premature death for women. The management of its cost is
important for both the national health insurance and the in-
dividual health-care providers. The objective of this study
was to assess the global medical cost of breast cancer, from
diagnosis to follow up, in a French medical centre.
METHODS: Our evaluation was based on a retrospec-
tive cohort of 120 patients followed from January 1995
to February 2000 at Centre René Huguenin (Saint-
Cloud). Comprehensive treatment schemes and clinical
events were reported from patients’ medical files. De-
tailed medical consumptions and mean duration of staff
occupation were obtained primarily from direct observa-
